Asbestos (2^nd Ed.) Risk Assessment, Epidemiology, and Health Effects, Second Edition

The first edition of Asbestos: Risk Assessment, Epidemiology, and Health Effects received critical acclaim due to the interdisciplinary nature of its content. Editors Ronald Dodson and Samuel Hammar have carefully kept this popular focus while updating and expanding the topics covered in the first edition with the help of internationally known experts. While there are hundreds of books available on many different aspects of asbestos, none contain the encyclopedic, comprehensive coverage you will find here.

See What?s New in the Second Edition:

• Definitions of asbestos by different methodologies and the potential impact that those forms have on health
• Internationally accepted sampling/analytical schemes
• Findings of major asbestos-related diseases that continue to increase in most industrialized countries where asbestos is widely used
• Information on asbestos-induced diseases in biological systems
• Expanded regulations chapter

Copiously illustrated with diagrams, tables, and photographs, including some in color, the book remains an interdisciplinary resource on the major issues in asbestos exposure and human health, with coverage that spans history, pathology, and epidemiology as well as sampling, analysis, and regulatory issues. The editors? expertise and careful updating set this book apart, making it a comprehensive resource that interlinks diverse specialties. They provide an updated and expanded state-of-the-art discussion of important interdisciplinary factors associated with asbestos-related issues in an easy-to-use reference.

The History of Asbestos Utilization and Recognition of Asbestos-Induced Diseases. Asbestos Analysis Methods. Analysis and Relevance of Asbestos Burden in Tissue. The Molecular Pathogenesis of Asbestos-Related Disorders. Epidemiology of Asbestos-Related Diseases and the Knowledge that Led to What is Known Today. Asbestos and Carcinoma of the Lung. Asbestos and Mesothelioma. Asbestos and Other Cancers: Pseudomesotheliomatous Lung Carcinoma, Laryngeal Carcinoma, Gastrointestinal Carcinoma, Ovarian Carcinoma, Kidney Cancer, Lymphomas, Systemic Carcinogen. Asbestosis. Asbestos-Induced Pleural Disease. Uncommon Non-Malignant Asbestos-Induced Conditions: Lymphocytic Interstitial Pneumonitis; Localized Masses – Asbestomas, Bronchilitis Obliterans-Organizing Pneumonia Type Change (BOOP); Desquamative Interstitial Pneumonitis (DIP); Aspergillus-Induced Lung Changes; and Granulomatous Inflammatory Changes. Clinical Diagnosis and Management of Non-Malignant Asbestos-Related Diseases. Malignant Diseases Attributed to Asbestos Exposure. Core Curriculum for Practicing Physicians Related to Asbestos. Asbestos Regulations and Their Applications.